Laserfiche WebLink
Directly observed collections. If a direct observation collection is required of the employee, the Company <br />will ensure that the DOT requirements (i.e., direct observation by the same -sex collector, observation of body - <br />to -bottle urination, and use of full turn -around observation) procedures are followed. <br />4. PHMSA Inspection Protocol for Specimen Collection Sites <br />Compliance. "PHMSA's Substance Abuse Program Comprehensive Audit and Inspection Protocol Form, <br />Specimen Collection Sites, Form No,: 3.1.7 (Revision':2)" provides a separate inspection protocol for Specimen <br />Collection Sites. The Company provides this protocol to correspond with the detail found in the PHMSA Inspection <br />Form. As previously stated, the Company will ensure that all DOT drug tests comply with Part 40 requirements. <br />Collection Personnel. The Company will ensure that only qualified collectors are used to conduct Company <br />DOT tests. An immediate supervisor of an employee may be used in cases where there are no qualified collectors <br />available, and where their use is the only way to get the test conducted. Collectors will maintain documentation <br />to verify they meet training requirements and will make that documentation available to the Company on request. <br />If an error occurs causing a test to be cancelled and the error is directly attributed to the collector, the collector <br />will undergo error -correction training within 30 days of the date of notification of the error that led to the need for <br />training. <br />Collection Sites, Forms and Supplies. The Company will use designated collection sites that meet DOT <br />requirements. If the collection site uses a facility normally used for other purposes, the collector will ensure that it <br />meets DOT standards before continuing the collection. <br />Access to collection materials and specimens will be restricted, and the facility will be secured against access during <br />the procedure to ensure privacy to the employee and prevent distraction of the collector. Limited -access signs <br />will be posted as necessary. The collector will maintain personal control over each specimen and CCF throughout <br />the collection process and will prevent unauthorized personnel from entering any party of the site in which urine <br />specimens are collected or stored. The current CCF and a collection kit, that meets the requirements of Appendix <br />A to Part 40, will be used for DOT collections. <br />Specimen Collections. Collectors will explain the basic collection procedures to the employee, including showing <br />the employee the instructions on the back of the CCF. In most all collections, the Company will provide the employee <br />with a kit and CCF to carry to the collection site. In other collections, collectors will provide the employee with an <br />ndividually wrapped or sealed collection container from the collection kit materials. <br />Precautions will be taken to ensure that unadulterated specimens are obtained and correctly identified. Specimen <br />integrity will be maintained by: bluing agents being added in the toilet tank and all water sources secured; positive <br />photo identification of the employee for collection, notification of the DER if the employee fails to arrive at the <br />assigned time; having the employee remove any unnecessary outer garments (purses or briefcases will remain with <br />the outer garments); having employees wash and dry their hands; and, to the greatest extent possible, the collector <br />will keep an employee's collection container within view of both the collector and the employee between the time the <br />employee has urinated and the specimen is sealed. Any unusual behavior will be noted on the CCF. <br />Following the collection, the specimen will be checked for sufficient volume (i.e., 45 mL), acceptable temperature <br />range (i.e., between 90-100 degrees F), and shows no signs of tampering (e.g., color, odor). Having problematic <br />ssues with specimen volume, the collector will follow DOT's "shy bladder" procedures; problems with temperature <br />or tampering will result in the collector conducting a second collection under direct observation (see Section V.2, <br />"Drug Tests That Require Direct Observation Procedures"), Direct observation procedures will be used for all <br />collections where the reason -for -test is either return -to -duty or follow-up. Direct observation procedures will also <br />be used for collections when a specimen is provided and the temperature is out of range, when the specimen <br />appears to have been tampered with or when a previous specimen has been reported as invalid, adulterated, <br />substituted or negative -dilute with a creatinine concentration greater than or equal to 2 mg/dL, but less than or <br />equal to 5mg/dL, as defined in Part 40. If the collector does a monitored collection, same gender monitors will be <br />used if the monitors are non -medical personnel. <br />Premium Concrete Services, Inc.- PHMSA DRUGlALCOHOL PLAN 23 <br />C� NATIONAL COMPLIANCE M�NAGEME�IT SERVIGF, INC. (NCNB) 2011 (update 2021). TM1e NCMS plan is <br />Iha subjerA of a regisieretl copyngh� entl Is proleGlad by copyM1ght 16�vs'in the U.S. aptl else,vhoro All nghls <br />e. <br />